Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Noble BioVentures

Noble BioVentures?uq=x1rNslWr

Noble BioVentures is a venture management group that leverages the infrastructure, technical capabilities and executive management talent pool of its commercial services affiliate Noble Life Sciences. The firm is focused on early stage technology-oriented biomedical companies developing novel therapeutic molecules and treatments, diagnostic products and/or tools for biomedical research and development. It was founded in 2009 and is based in Gaithersburg, Maryland.

Investor Status
Actively Seeking New Investments
Year Founded
Primary Investor Type
Venture Capital
Primary Office
  • Gaithersburg, MD
  • United States

+1 (301) 000-0000 000. 000

Noble BioVentures Investments (13)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Iterion Therapeutics 18-Jun-2015 Early Stage VC 000 Biotechnology Generating Revenue 0000000 000000 00.0
000000000 17-Jul-2014 00000 00000 000 Biotechnology Generating Revenue 00000 000000000
0000000000 08-Apr-2014 0000 00000 00000 Drug Discovery Startup 00000 000000000
0000000 30-Sep-2012 00000 00000 0000 Diagnostic Equipment Generating Revenue
000000000 00000000 21-Sep-2012 00000 00000 00.000 Biotechnology Profitable
00000 0000 0000000 30-Mar-2012 0000 00000 00000 Discovery Tools (Healthcare) Startup
0000 000000000000 07-Feb-2006 00000 00000 000.00 Pharmaceuticals Out of Business
000000000 00000000 09-Sep-2005 00000 00000 000.00 Biotechnology Profitable
Predix Pharmaceuticals Holdings 25-Jan-2005 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
Aryx Therapeutics 02-Jun-2004 Later Stage VC 0000 Pharmaceuticals Out of Business
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Noble BioVentures’s full profile, request a free trial.

Noble BioVentures Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
NexImmune 14-Feb-2017 Merger/Acquisition Completed
000000 00000000000 12-Nov-2014 000 000.00 Completed
Predix Pharmaceuticals Holdings 16-Aug-2006 Merger/Acquisition 0000 Completed
  • EPIX Pharmaceuticals
GeneOhm Sciences 14-Feb-2006 Merger/Acquisition 00000 Completed
To view this investor’s complete exits history, request access »

Noble BioVentures Team (11)

Name Title Deals Funds Boards Office Contact
E. Faye Coggins Executive Gaithersburg, MD
J. Michael Hamilton MD Executive Gaithersburg, MD
Makoto Yoshioka Ph.D Executive Gaithersburg, MD
Thomas Ng Ph.D Executive Gaithersburg, MD
Kenneth Carter Ph.D Co-Founder & Partner 0 0 Gaithersburg, MD
You’re viewing 5 of 11 team members. Get the full list »